...DNA samples. Leveraging somatic SNVs and fusions, LongSom found subclones with different predicted treatment outcomes. In summary, LongSom enables de novo
variant detection without the need for normal samples, facilitating the study of cancer evolution, clonal heterogeneity, and
treatment resistance...